Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ouissam Al Jarroudi

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Current Drug Targets|October 12, 2021
The Extracapsular Lymph Node Extension Predicts Outcomes in Colorectal Cancer: A Short ReviewRachid Jabi, Ouissam Al Jarroudi, Mohammed Bouziane
Gynecologic Oncology Reports|September 20, 2021
Ovarian cancer in Morocco: Time to act is nowKhalid El Bairi, Ouissam Al Jarroudi, Said Afqir
Frontiers in Oncology|October 11, 2021
Inexpensive Systemic Inflammatory Biomarkers in Ovarian Cancer: An Umbrella Systematic Review of 17 Prognostic Meta-AnalysesKhalid El Bairi, Ouissam Al Jarroudi, Said Afqir
Gynecologic Oncology Reports|June 21, 2021
Tracing ovarian cancer research in Morocco: A bibliometric analysisKhalid El Bairi, Ouissam Al Jarroudi, Said Afqir
JCO Global Oncology|December 15, 2021
Practical Tools and Guidelines for Young Oncologists From Resource-Limited Settings to Publish Excellence and Advance Their CareerKhalid El Bairi, Ouissam Al Jarroudi, Said Afqir
Seminars in Cancer Biology|April 4, 2021
Revisiting antibody-drug conjugates and their predictive biomarkers in platinum-resistant ovarian cancerKhalid El Bairi, Ouissam Al Jarroudi, Said Afqir
Cancer Treatment and Research|January 4, 2024
Antibody-Drug Conjugates: A New Therapeutic Approach for Triple-Negative Breast CancerOuissam Al Jarroudi, Khalid El Bairi, Giuseppe Curigliano, et al.
Cancer Treatment and Research|January 4, 2024
Immune-Checkpoint Inhibitors: A New Line of Attack in Triple-Negative Breast CancerOuissam Al Jarroudi, Khalid El Bairi, Giuseppe Curigliano, et al.
Contemporary Oncology (Poznan, Poland)|May 4, 2022
Bevacizumab in metastatic colorectal cancer in a real-life setting - toxicity profile, survival outcomes, and impact of tumor sidednessHind Chibani, Khalid El Bairi, Ouissam Al Jarroudi, et al.
Cureus|February 7, 2024
A Case Report of Uterine Müllerian Adenosarcoma With Sarcomatous OvergrowthMohammed Bendimya, Ouissam Al Jarroudi, Sami Aziz Brahmi, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Current Drug Targets|October 12, 2021
The Extracapsular Lymph Node Extension Predicts Outcomes in Colorectal Cancer: A Short ReviewRachid Jabi, Ouissam Al Jarroudi, Mohammed Bouziane
Gynecologic Oncology Reports|September 20, 2021
Ovarian cancer in Morocco: Time to act is nowKhalid El Bairi, Ouissam Al Jarroudi, Said Afqir
Frontiers in Oncology|October 11, 2021
Inexpensive Systemic Inflammatory Biomarkers in Ovarian Cancer: An Umbrella Systematic Review of 17 Prognostic Meta-AnalysesKhalid El Bairi, Ouissam Al Jarroudi, Said Afqir
Gynecologic Oncology Reports|June 21, 2021
Tracing ovarian cancer research in Morocco: A bibliometric analysisKhalid El Bairi, Ouissam Al Jarroudi, Said Afqir
JCO Global Oncology|December 15, 2021
Practical Tools and Guidelines for Young Oncologists From Resource-Limited Settings to Publish Excellence and Advance Their CareerKhalid El Bairi, Ouissam Al Jarroudi, Said Afqir
Seminars in Cancer Biology|April 4, 2021
Revisiting antibody-drug conjugates and their predictive biomarkers in platinum-resistant ovarian cancerKhalid El Bairi, Ouissam Al Jarroudi, Said Afqir
Cancer Treatment and Research|January 4, 2024
Antibody-Drug Conjugates: A New Therapeutic Approach for Triple-Negative Breast CancerOuissam Al Jarroudi, Khalid El Bairi, Giuseppe Curigliano, et al.
Cancer Treatment and Research|January 4, 2024
Immune-Checkpoint Inhibitors: A New Line of Attack in Triple-Negative Breast CancerOuissam Al Jarroudi, Khalid El Bairi, Giuseppe Curigliano, et al.
Contemporary Oncology (Poznan, Poland)|May 4, 2022
Bevacizumab in metastatic colorectal cancer in a real-life setting - toxicity profile, survival outcomes, and impact of tumor sidednessHind Chibani, Khalid El Bairi, Ouissam Al Jarroudi, et al.
Cureus|February 7, 2024
A Case Report of Uterine Müllerian Adenosarcoma With Sarcomatous OvergrowthMohammed Bendimya, Ouissam Al Jarroudi, Sami Aziz Brahmi, et al.
Pageof 6